TTBK1 Peptide Reference: GTX85349-PEP TTBK1 peptide is used for blocking the activity of TTBK1 antibody (catalog number GTX85349). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human GDF-15 Reference: GFH171-100 Growth Differentiation Factor 15 (GDF-15) is a member of the Transforming Growth Factor β (TGF-β) family and is made by the placenta and cardiovascular tissues. GDF-15 regulates inflammatory and apoptotic pathways during cellular stress and injury. GDF-15 is emerging as a biomarker of early heart disease, such that increased levels of circulating GDF-15 are associated with an increased risk of developing heart failure.
OCC1 Peptide Reference: GTX85350-PEP OCC-1 peptide is used for blocking the activity of OCC-1 antibody (catalog number GTX8535). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human GDF-15 Reference: GFH171-1000 Growth Differentiation Factor 15 (GDF-15) is a member of the Transforming Growth Factor β (TGF-β) family and is made by the placenta and cardiovascular tissues. GDF-15 regulates inflammatory and apoptotic pathways during cellular stress and injury. GDF-15 is emerging as a biomarker of early heart disease, such that increased levels of circulating GDF-15 are associated with an increased risk of developing heart failure.
OCC1 Peptide Reference: GTX85351-PEP OCC-1 peptide is used for blocking the activity of OCC-1 antibody (catalog number GTX85351). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human GDF-15 (Animal-Free) Reference: GFH171AF-5 Growth Differentiation Factor 15 (GDF-15) is a member of the Transforming Growth Factor β (TGF-β) family and is made by the placenta and cardiovascular tissues. GDF-15 regulates inflammatory and apoptotic pathways during cellular stress and injury. GDF-15 is emerging as a biomarker of early heart disease, such that increased levels of circulating GDF-15 are associated with an increased risk of developing heart failure.
Recombinant Human GDF-15 (Animal-Free) Reference: GFH171AF-20 Growth Differentiation Factor 15 (GDF-15) is a member of the Transforming Growth Factor β (TGF-β) family and is made by the placenta and cardiovascular tissues. GDF-15 regulates inflammatory and apoptotic pathways during cellular stress and injury. GDF-15 is emerging as a biomarker of early heart disease, such that increased levels of circulating GDF-15 are associated with an increased risk of developing heart failure.
TOM70 Peptide Reference: GTX85353-PEP TOM7 peptide is used for blocking the activity of TOM7 antibody (catalog number GTX85353). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human GDF-15 (Animal-Free) Reference: GFH171AF-100 Growth Differentiation Factor 15 (GDF-15) is a member of the Transforming Growth Factor β (TGF-β) family and is made by the placenta and cardiovascular tissues. GDF-15 regulates inflammatory and apoptotic pathways during cellular stress and injury. GDF-15 is emerging as a biomarker of early heart disease, such that increased levels of circulating GDF-15 are associated with an increased risk of developing heart failure.
NIPSNAP3B Peptide Reference: GTX85354-PEP NIPSNAP3B peptide is used for blocking the activity of NIPSNAP3B antibody (catalog number GTX85354). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 3 min at 37oC.
Recombinant Human GDF-15 (Animal-Free) Reference: GFH171AF-1000 Growth Differentiation Factor 15 (GDF-15) is a member of the Transforming Growth Factor β (TGF-β) family and is made by the placenta and cardiovascular tissues. GDF-15 regulates inflammatory and apoptotic pathways during cellular stress and injury. GDF-15 is emerging as a biomarker of early heart disease, such that increased levels of circulating GDF-15 are associated with an increased risk of developing heart failure.